Cargando…

Effects of miR-33 Deficiency on Metabolic and Cardiovascular Diseases: Implications for Therapeutic Intervention

MicroRNAs (miRNAs) are small noncoding RNAs that post-transcriptionally inhibit gene expression. These small molecules are involved in several biological conditions such as inflammation, cell growth and proliferation, and regulation of energy metabolism. In the context of metabolic and cardiovascula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ortega, Rebeca, Liu, Bo, Persaud, Shanta J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342147/ https://www.ncbi.nlm.nih.gov/pubmed/37445956 http://dx.doi.org/10.3390/ijms241310777

Ejemplares similares

miR33a/miR33b* and miR122 as Possible Contributors to Hepatic Lipid Metabolism in Obese Women with Nonalcoholic Fatty Liver Disease
por: Auguet, Teresa, et al.
Publicado: (2016)

MiR-33 connects cholesterol to the cell cycle
por: Inukai, Sachi, et al.
Publicado: (2012)

Is miR-21 A Therapeutic Target in Cardiovascular Disease?
por: Holland, Antoinette, et al.
Publicado: (2023)

Mycobacterium tuberculosis induces the miR-33 locus to reprogram autophagy and host lipid metabolism
por: Ouimet, Mireille, et al.
Publicado: (2016)

Metabolic rewiring in keratinocytes by miR‐31‐5p identifies therapeutic intervention for psoriasis
por: Wang, Mao‐Jie, et al.
Publicado: (2023)

The function of miR-143, miR-145 and the MiR-143 host gene in cardiovascular development and disease
por: Vacante, Francesca, et al.
Publicado: (2019)

APE1 controls DICER1 expression in NSCLC through miR-33a and miR-130b
por: Antoniali, Giulia, et al.
Publicado: (2022)

Serum microRNA array analysis identifies miR-140-3p, miR-33b-3p and miR-671-3p as potential osteoarthritis biomarkers involved in metabolic processes
por: Ntoumou, E., et al.
Publicado: (2017)

Advances in miR-132-Based Biomarker and Therapeutic Potential in the Cardiovascular System
por: Xu, Kaizu, et al.
Publicado: (2021)

Resveratrol and EGCG bind directly and distinctively to miR-33a and miR-122 and modulate divergently their levels in hepatic cells
por: Baselga-Escudero, Laura, et al.
Publicado: (2014)

Chronic Administration of Proanthocyanidins or Docosahexaenoic Acid Reversess the Increase of miR-33a and miR-122 in Dyslipidemic Obese Rats
por: Baselga-Escudero, Laura, et al.
Publicado: (2013)

Downregulation of miR‐33b promotes non‐small cell lung cancer cell growth through reprogramming glucose metabolism miR‐33b regulates non‐small cell lung cancer cell growth
por: Zhai, Shengping, et al.
Publicado: (2018)

miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies
por: Amodio, Nicola, et al.
Publicado: (2015)

MiR-33a plays an crucial role in the proliferation of bovine preadipocytes
por: Zhang, Wenzhen, et al.
Publicado: (2021)

Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice
por: Goedeke, Leigh, et al.
Publicado: (2014)

Protective role of ABCA1 in ischemic preconditioning is mediated by downregulation of miR-33-5p and miR-135-5p
por: Sung, Hye Youn, et al.
Publicado: (2021)

Oligoasthenoteratozoospermia and Infertility in Mice Deficient for miR-34b/c and miR-449 Loci
por: Comazzetto, Stefano, et al.
Publicado: (2014)

Genetic versus Non-Genetic Regulation of miR-103, miR-143 and miR-483-3p Expression in Adipose Tissue and Their Metabolic Implications—A Twin Study
por: Bork-Jensen, Jette, et al.
Publicado: (2014)

Potential Clinical Implications of miR-1 and miR-21 in Heart Disease and Cardioprotection †
por: Kura, Branislav, et al.
Publicado: (2020)

Investigation of the relationship between miR-33a, miR-122, erythrocyte membrane fatty acids profile, and serum lipids with components of metabolic syndrome in type 2 diabetic patients
por: Masoudi, Fatemeh, et al.
Publicado: (2022)

Mir-1, miR-122, miR-132, and miR-133 Are Related to Subclinical Aortic Atherosclerosis Associated with Metabolic Syndrome
por: Šatrauskienė, Agnė, et al.
Publicado: (2021)

hsa-miR-33-5p as a Therapeutic Target Promotes Apoptosis of Breast Cancer Cells via Selenoprotein T
por: Zhuang, Wei, et al.
Publicado: (2021)

miR-33 and RIP140 participate in LPS-induced acute lung injury
por: LI, Hua, et al.
Publicado: (2019)

TB-3 miR-33a depletion accelerate medulloblastoma generation and invasion
por: Mineharu, Yohei, et al.
Publicado: (2021)

miR-33a and Its Association with Lipid Profile in Patients with Carotid Atherosclerosis
por: Tanashyan, Marine M., et al.
Publicado: (2023)

The Accelerated Progression of Atherosclerosis Correlates with Decreased miR-33a and miR-21 and Increased miR-122 and miR-3064-5p in Circulation and the Liver of ApoE-/- Mice with Streptozocin (STZ)-Induced Type 2 Diabetes
por: Luo, Hui-Yu, et al.
Publicado: (2022)

A mouse model of miR-96, miR-182 and miR-183 misexpression implicates miRNAs in cochlear cell fate and homeostasis
por: Weston, Michael D., et al.
Publicado: (2018)

MiR-223-3p in Cardiovascular Diseases: A Biomarker and Potential Therapeutic Target
por: Zhang, Meng-Wan, et al.
Publicado: (2021)

Targeting hepatic miR-221/222 for therapeutic intervention of nonalcoholic steatohepatitis in mice
por: Jiang, Xiuli, et al.
Publicado: (2018)

Diagnostic and prognostic potential of serum miR-7, miR-16, miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer patients
por: Meng, Xiaodan, et al.
Publicado: (2015)

MiR-222 in Cardiovascular Diseases: Physiology and Pathology
por: Ding, Shengguang, et al.
Publicado: (2017)

MiR-125 Family in Cardiovascular and Cerebrovascular Diseases
por: Wang, Yang, et al.
Publicado: (2021)

Role of miR-182 in cardiovascular and cerebrovascular diseases
por: Pei, Gaiqin, et al.
Publicado: (2023)

Expression of miR-33 from an SREBF2 Intron Targets the FTO Gene in the Chicken
por: Shao, Fang, et al.
Publicado: (2014)

Xuezhikang Therapy Increases miR-33 Expression in Patients with Low HDL-C Levels
por: Cao, Ruihua, et al.
Publicado: (2014)

miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity
por: Allen, Ryan M, et al.
Publicado: (2012)

Detection of miR-33 Expression and the Verification of Its Target Genes in the Fatty Liver of Geese
por: Zheng, Yun, et al.
Publicado: (2015)

miR-33a is a tumor suppressor microRNA that is decreased in prostate cancer
por: Karatas, Omer Faruk, et al.
Publicado: (2017)

Hepatocyte miR‐33a mediates mitochondrial dysfunction and hepatosteatosis by suppressing NDUFA5
por: Nie, Hezhongrong, et al.
Publicado: (2018)

Uncovering the Specific Functions of miR-33 in Regulation of Feeding and Cardiometabolic Diseases Linked to Aging
por: Price, Nathan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rdd9jmleko8afarjpkf0dp42cn